Trial of an Exercise Intervention for Children With Haemophilia

Launched by EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST · May 30, 2023

Keywords

ClinConnect Summary

**Trial Summary: Exercise for Children with Hemophilia**

This clinical trial is exploring whether a special exercise program can help boys aged 6 to 12 years with hemophilia become stronger and more active. Many boys with hemophilia want to participate in games and activities with their friends, but there isn’t enough evidence to know if strengthening exercises are safe and beneficial for them. In this study, some boys will follow a new exercise program designed by healthcare professionals, while others will continue with their usual care. The goal is to see if the exercise helps improve their muscle strength and overall participation in activities.

To be eligible for this trial, boys must be between 6 and 12 years old and have severe or moderate hemophilia A or B. However, children with certain conditions, such as von Willebrand disease or recent injuries to the lower limbs, cannot participate. Throughout the 12-week study, participants will be monitored to ensure their safety and to gather information about how the exercise impacts their health. This research aims to help understand how physical activity can support children with hemophilia in living a more active and joyful life.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • • Children aged 6-12 years, with severe or moderate haemophilia A or B
• Exclusion Criteria:
• • von Willebrand disease
• • past history of fracture or trauma to the lower limb
• • orthopaedic surgery
• • acquired brain injury or any other disturbance of the central nervous system; joint or muscle bleed in the lower limb in the past 6 weeks
• • presence of lower limb pain or unable to fully comply with verbal instructions.